New cancer clinical trial: Entinostat Versus Placebo Combined With Endocrine Therapy in Chinese Patients With Advanced Breast Cancer in Chinese Patients With Hormone Receptor-Positive Advanced Breast Cancer

Published on: May 28, 2018 at 12:00PM
Condition:   Advanced Breast Cancer
Interventions:   Drug: Entinostat;   Drug: Placebo;   Drug: Exemestane
Sponsor:   EddingPharm Oncology Co., LTD.
Not yet recruiting
https://ift.tt/2L27Hl2